Founded in 2016, WINPRO products use clinically proven animal blood proteins to help prevent and combat the negative effects of stress-induced inflammation in dogs. Many of today’s most common canine health problems are caused by inflammation which is often caused by stress.
The company plans to use the new round of funding on new product development and marketing.
“WINPRO Pet was looking to take the next step and Next Level Ventures brings both needed capital and business expertise,” said WINPRO Pet founder Bill Bernardo in a release. “I’m especially excited about our future growth prospects especially as they relate to new dog essentials and possibly other species too.”
WINPRO is the 27th startup to receive investment from Next Level Ventures, according to the firm’s portfolio page.
“There’s never been a more exciting time to be in the pet health industry,” said WINPRO President Tim Mitchum. “With the continued support of our amazing partners, we are now positioned to bring WINPRO Pet’s truly unique and innovative products to more dogs around the world.”